Strategic Directions
Address the pipeline issue for advancing drug development through molecular imaging
- Encourage and foster multidisciplinary research towards development of clinically validated molecular imaging based companion diagnostics (MICOD)
- Provide a platform for productive discussions around development of molecular imaging companion diagnostics and its challenges
- Attract academics, industry professionals, CROs, Biotechs and clinicians to pursue a common goal of developing MICOD and its integration in drug development
Help facilitate the successful development of MICOD
- Encourage and reward innovative science that helped development of MICOD
- Provide a platform to address Clinical manufacturing issues and Phase 1 clinical trials
- Establish MICOD/WMIS as a ‘central body’ to help address regulatory and reimbursement issues related to MICOD